Preeclampsia Diagnostics Market Market Trends

  • Report ID: 4412
  • Published Date: Sep 09, 2025
  • Report Format: PDF, PPT

Preeclampsia Diagnostics Market Growth Drivers and Challenges:

Growth Drivers

  • Market Expansion in Emerging Economies – The preeclampsia diagnostics market is growing rapidly in emerging economies such as India and China. This is due to several factors such as rising incomes, increasing access to healthcare and increasing awareness about preeclampsia.  This factor is anticipated to drive the growth of the preeclampsia diagnostics market in the anticipated time period.

  • Development of Innovative Tests - The development of early diagnostic tests for preeclampsia will help reduce maternal and neonatal mortality. Awareness of pre-eclampsia has increased recently, mainly due to campaigns by patient advocacy groups and welfare associations. This remains an important factor providing profitable growth opportunities for innovative test development given the significant unmet need for diagnosing pre-eclampsia worldwide.

Challenges

  • Lack of Reimbursement - The lack of reimbursement will limit the market growth during the forecast period. Most health insurance policies do not cover reimbursement for preeclampsia tests. Lack of reimbursement policy and high cost pose barriers to adoption of preeclampsia testing. Some state and federal officials as well as health officials have publicly encouraged payers to review their insurance policies for Diagnostics for preeclampsia. However, the market still lacks reimbursement services for preeclampsia testing. Such factors limit the growth of the market. Therefore, these factors are expected to restrict the market growth of preeclampsia diagnostics market in the projected timeframe.

  • High Cost of Preeclampsia Diagnostics is Expected to Hamper the Market Growth in Upcoming Period.

  • Lack of Skilled Professionals is Estimated to Restrict the Market Expansion in Future Time.

Base Year

2025

Forecast Period

2026-2035

CAGR

10.2%

Base Year Market Size (2025)

USD 2.27 Billion

Forecast Year Market Size (2035)

USD 6 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of preeclampsia diagnostics is evaluated at USD 2.48 Billion.

The global preeclampsia diagnostics market size was worth around USD 2.27 Billion in 2025 and is set to register a CAGR of more than 10.2%, exceeding USD 6 Billion revenue by 2035.

The North America preeclampsia diagnostics market will secure around 35% share by 2035, fueled by a focus on drug delivery, vaccine development, advancements in biotechnology, and maternal health awareness.

Key players in the market include of Cardinal Health Inc., Diabetomics Inc., F. Hoffmann La Roche Ltd., Thermo Fisher Inc., Biora Therapeutics Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos